Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient.
Tetsuju
Sekiryu
S
Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan. sekiryu@fmu.ac.jp.
Iida
Tomohiro
T
Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan.
Kaneko
Hisatoshi
H
Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan.
Saito
Masaaki
M
Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan.
D000998:Antiviral Agents / Q000627:therapeutic use; D017726:Cytomegalovirus Retinitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005451:Fluorescein Angiography; D015774:Ganciclovir / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D016867:Immunocompromised Host; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012170:Retinal Vein Occlusion / Q000188:drug therapy; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014822:Vitreous Body
D000998:Antiviral Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide; D015774:Ganciclovir